$0.770000
0.022.65%
Last update: 7:09 PM
15 minutes delayed
Comments
Loading...
Bolt Biotherapeutics
BOLTNASDAQ
want to know what
the Bulls & Bears Say?
Bolt Biotherapeutics (NASDAQ:BOLT) Stock, Analyst Ratings, Price Targets, Forecasts
Bolt Biotherapeutics Inc has a consensus price target of $2.38 based on the ratings of 7 analysts. The high is $4 issued by SVB Leerink on May 12, 2023. The low is $1 issued by Leerink Partners on May 15, 2024. The 3 most-recent analyst ratings were released by Leerink Partners, Stifel, and HC Wainwright & Co. on May 15, 2024, May 15, 2024, and March 22, 2024, respectively. With an average price target of $3.5 between Leerink Partners, Stifel, and HC Wainwright & Co., there's an implied 354.55% upside for Bolt Biotherapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Leerink Partners
Stifel
SVB Leerink
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Bolt Biotherapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 29.87% | Leerink Partners | Daina Graybosch | $3 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/15/2024 | Buy Now | — | Jones Trading | Soumit Roy | — | Downgrade | Buy → Hold | Get Alert |
| 05/15/2024 | Buy Now | — | HC Wainwright & Co. | Edward White | — | Downgrade | Buy → Neutral | Get Alert |
| 05/15/2024 | Buy Now | 94.81% | Stifel | Stephen Willey | $6 → $1.5 | Downgrade | Buy → Hold | Get Alert |
| 05/15/2024 | Buy Now | — | Guggenheim | Michael Schmidt | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | $8 → $8 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 06/05/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 05/12/2023 | Buy Now | 419.48% | SVB Leerink | Daina Graybosch | → $4 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/12/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/30/2023 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | 289.61% | Morgan Stanley | Matthew Harrison | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 10/04/2022 | Buy Now | 938.96% | HC Wainwright & Co. | Edward White | → $8 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | 419.48% | SVB Leerink | Daina Graybosch | $8 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/17/2022 | Buy Now | 549.35% | Morgan Stanley | Matthew Harrison | $7 → $5 | Maintains | Equal-Weight | Get Alert |
| 01/06/2022 | Buy Now | 1328.57% | Morgan Stanley | Matthew Harrison | $45 → $11 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/10/2021 | Buy Now | 4185.71% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
| 08/16/2021 | Buy Now | 4445.45% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Bolt Biotherapeutics (BOLT) stock?
The latest price target for Bolt Biotherapeutics (NASDAQ:BOLT) was reported by Leerink Partners on May 15, 2024. The analyst firm set a price target for $1.00 expecting BOLT to rise to within 12 months (a possible 29.87% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bolt Biotherapeutics (BOLT)?
The latest analyst rating for Bolt Biotherapeutics (NASDAQ:BOLT) was provided by Leerink Partners, and Bolt Biotherapeutics downgraded their market perform rating.
When was the last upgrade for Bolt Biotherapeutics (BOLT)?
The last upgrade for Bolt Biotherapeutics Inc happened on May 12, 2023 when SVB Leerink raised their price target to $4. SVB Leerink previously had a market perform for Bolt Biotherapeutics Inc.
When was the last downgrade for Bolt Biotherapeutics (BOLT)?
The last downgrade for Bolt Biotherapeutics Inc happened on May 15, 2024 when Leerink Partners changed their price target from $3 to $1 for Bolt Biotherapeutics Inc.
When is the next analyst rating going to be posted or updated for Bolt Biotherapeutics (BOLT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bolt Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bolt Biotherapeutics was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Bolt Biotherapeutics (BOLT) correct?
While ratings are subjective and will change, the latest Bolt Biotherapeutics (BOLT) rating was a downgraded with a price target of $3.00 to $1.00. The current price Bolt Biotherapeutics (BOLT) is trading at is $0.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.